Rocket Pharmaceuticals Inc (RCKT)

Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	3.28%46.92	48.51	43.96	52.25	71.15
Research and Development	6.22%29.50	31.45	29.35	34.07	42.66
Interest Income/Expense	0.47	0.47	0.47	0.47	0.47
Operating Income/Loss	3.28%-46.92	-48.51	-43.96	-52.25	-71.15
Income/Loss From Continuing Operations Before Tax	131.84	-	-42.54	-50.33	-68.92
Income Tax Expense/Benefit	8.62	-	-	-	-
	358.89%123.21	-47.59	-42.54	-50.33	-68.92
Attributable To Parent	358.89%123.21	-47.59	-42.54	-50.33	-68.92
Available To Common Stockholders, Basic	358.89%123.21	-47.59	-42.54	-50.33	-68.92
Basic Average Shares	0.63%112.84	112.13	0.22	111.57	111.02
Diluted Average Shares	2.12%114.51	112.13	0.22	111.57	111.02
Basic Earnings Per Share	359.52%1.09	-0.42	-0.38	-0.45	-0.62
Diluted Earnings Per Share	357.14%1.08	-0.42	-0.38	-0.45	-0.62